{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:32:55Z","timestamp":1773768775185,"version":"3.50.1"},"posted":{"date-parts":[[2026,3,3]]},"group-title":"In Review","reference-count":56,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,1,28]]},"abstract":"<title>Abstract<\/title>\n                <p>Background\n Migraine is a debilitating neurological disorder affecting\u2009~\u200915% of the global population with greater prevalence in females. Cannabinoid 1 and 2 receptor (CB1R and CB2R) agonists alleviate migraine symptoms. However, central nervous system (CNS) side effects mediated by CB1Rs limit their widespread use. We developed peripherally restricted cannabinoids (PRCBs) which lack CNS side effects. Here we examine actions of a PRCB on behavioral and physiological parameters in a mouse migraine model.\nMethods\n Female 4-week-old C57BL\/6J mice were acclimated to measurements of head withdrawal threshold (HWT) responses to periorbital von Frey filaments. After several days of baseline testing, mice (under brief isoflurane anesthesia) were administered pH-6.0 or pH-7.4 saline (4.5\u00b5L) supradurally via a 33-gauge cannula through the skin and connective tissue by taking advantage of unfused cranial sutures at bregma, followed 3-days later, by responses to a mild (pH-7.0 saline) supradural stimulation. The CB1R\/CB2R agonist PRCB, PrNMI (5\u00b5M), was co-applied with pH-6.0 saline with or without the peripherally-restricted selective CB1R antagonist, 18A (20\u00b5M) or the selective CB2R antagonist, SR144528 (20\u00b5M). The potent selective CB2R agonist RNB61 (5\u00b5M) was also co-applied. Patch clamp recordings were obtained in retrogradely-labeled dural trigeminal ganglion (dTG) neurons acutely isolated from mice treated 3-days earlier with supradural pH-7.4 or pH-6.0 saline and 4% fluorogold.\nResults\n Supradural pH-6.0 (but not pH-7.4) treatment produced allodynia symptoms which recovered by 48-hrs but were renewed by pH-7.0 supradural treatment. Supradural co-administration of pH-6.0\/PrNMI prevented both the initial and latent allodynia symptoms. Co-administration of pH-6.0\/PrNMI with 18A, or SR144528, abolished the preventative effects of PrNMI. Co-administration of pH-6.0\/RNB61 did not prevent the initial allodynia or latent sensitization. Co-administration of pH-7.0\/PrNMI did not prevent latent hypersensitivity. All dTGs had A\u03b4- or C-type nociceptor characteristics. Acid-induced depolarizations were enhanced in dTGs from pH-6.0-treated mice. PrNMI (1\u00b5M) decreased acid-induced depolarizations in dTGs from pH-7.4- (but not pH-6.0)-treated mice. RNB61 (0.5\u00b5M) had no effect on acid-induced depolarizations in dTGs from either group.\nConclusions\n These findings indicate that PrNMI prevents acid-induced sensitization and allodynia by activating peripheral neuronal CB1Rs and non-neuronal CB2Rs. CB2R activation alone is insufficient, and once sensitized, combined CB1R\/CB2R activation loses efficacy.<\/p>","DOI":"10.21203\/rs.3.rs-8714966\/v1","type":"posted-content","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T14:31:36Z","timestamp":1772548296000},"source":"Crossref","is-referenced-by-count":0,"title":["Cannabinoid actions on sensitized dural nociceptors in a non-surgical mouse model of migraine-like pain"],"prefix":"10.21203","author":[{"given":"Yoshihiro","family":"Kitaoka","sequence":"first","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyle","family":"Whyland","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiwei","family":"Li","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyotaro","family":"Koshika","sequence":"additional","affiliation":[{"name":"Tokyo Dental College"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Niigata University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yatendra","family":"Mulpuri","sequence":"additional","affiliation":[{"name":"New York University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Spigelman","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Headache Classification Committee of the International Headache Society (IHS) (2018) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1-211","DOI":"10.1177\/0333102417738202"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S1474-4422(19)30185-1","article-title":"Migraine and the trigeminovascular system-40 years and counting","volume":"18","author":"Ashina M","year":"2019","unstructured":"Ashina M, Hansen JM, Do TP, Melo-Carrillo A, Burstein R, Moskowitz MA (2019) Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol 18:795\u2013804","journal-title":"Lancet Neurol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.mayocp.2023.07.003","article-title":"Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside","volume":"99","author":"Ashina M","year":"2024","unstructured":"Ashina M, Hoffmann J, Ashina H, Hay DL, Flores-Montanez Y, Do TP, De Icco R, Dodick DW (2024) Pharmacotherapies for Migraine and Translating Evidence From Bench to Bedside. Mayo Clin Proc 99:285\u2013299","journal-title":"Mayo Clin Proc"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ana.410280213","article-title":"Vasoactive peptide release in the extracerebral circulation of humans during migraine headache","volume":"28","author":"Goadsby PJ","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183\u2013187","journal-title":"Ann Neurol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pain.2003.09.008","article-title":"NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release","volume":"106","author":"Juhasz G","year":"2003","unstructured":"Juhasz G, Zsombok T, Modos EA, Olajos S, Jakab B, Nemeth J, Szolcsanyi J, Vitrai J, Bagdy G (2003) NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release. Pain 106:461\u2013470","journal-title":"Pain"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1046\/j.1468-2982.2002.00310.x","article-title":"CGRP may play a causative role in migraine","volume":"22","author":"Lassen LH","year":"2002","unstructured":"Lassen LH, Haderslev PA, Jacobsen VB, Iversen HK, Sperling B, Olesen J (2002) CGRP may play a causative role in migraine. Cephalalgia 22:54\u201361","journal-title":"Cephalalgia"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/head.12570","article-title":"Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been","volume":"55","author":"Baron EP","year":"2015","unstructured":"Baron EP (2015) Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been. Headache 55:885\u2013916","journal-title":"Headache"},{"key":"ref8","first-page":"e32622","article-title":"Efficacy and Safety of Medical Marijuana in Migraine Headache: A Systematic Review","volume":"14","author":"Sherpa ML","year":"2022","unstructured":"Sherpa ML, Shrestha N, Ojinna BT, Ravi N, Shantha Kumar V, Choday S, Parisapogu A, Tran HH, Kc A, Elshaikh AO (2022) Efficacy and Safety of Medical Marijuana in Migraine Headache: A Systematic Review. Cureus 14:e32622","journal-title":"Cureus"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3331024251314487","DOI":"10.1177\/03331024251314487","article-title":"Combined effects of cannabidiol and \u22069-tetrahydrocannabinol alleviate migraine-like symptoms in mice","volume":"45","author":"Zorrilla E","year":"2025","unstructured":"Zorrilla E, Krivoshein G, Kuburas A, Schenke M, Pi\u00f1a CL, van Heiningen SH, Waite JS, Dehghani A, Castonguay WC, Flinn HC, van den Maagdenberg A, Russo AF, Tolner EA, Wattiez AS (2025) Combined effects of cannabidiol and \u22069-tetrahydrocannabinol alleviate migraine-like symptoms in mice. Cephalalgia 45:3331024251314487","journal-title":"Cephalalgia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/nn1916","article-title":"Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors","volume":"10","author":"Agarwal N","year":"2007","unstructured":"Agarwal N, Pacher P, Tegeder I, Amaya F, Constantin CE, Brenner GJ, Rubino T, Michalski CW, Marsicano G, Monory K, Mackie K, Marian C, Batkai S, Parolaro D, Fischer MJ, Reeh P, Kunos G, Kress M, Lutz B, Woolf CJ, Kuner R (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors. Nat Neurosci 10:870\u2013879","journal-title":"Nat Neurosci"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neuropharm.2018.07.002","article-title":"Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation","volume":"139","author":"Mulpuri Y","year":"2018","unstructured":"Mulpuri Y, Marty VN, Munier JJ, Mackie K, Schmidt BL, Seltzman HH, Spigelman I (2018) Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation. Neuropharmacology 139:85\u201397","journal-title":"Neuropharmacology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"7525","DOI":"10.1021\/acs.jmedchem.6b00516","article-title":"Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain","volume":"59","author":"Seltzman HH","year":"2016","unstructured":"Seltzman HH, Shiner C, Hirt EE, Gilliam AF, Thomas BF, Maitra R, Snyder R, Black SL, Patel PR, Mulpuri Y, Spigelman I (2016) Peripherally Selective Cannabinoid 1 Receptor (CB1R) Agonists for the Treatment of Neuropathic Pain. J Med Chem 59:7525\u20137543","journal-title":"J Med Chem"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1097\/j.pain.0000000000001278","article-title":"Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain","volume":"159","author":"Zhang H","year":"2018","unstructured":"Zhang H, Lund DM, Ciccone HA, Staatz WD, Ibrahim MM, Largent-Milnes TM, Seltzman HH, Spigelman I, Vanderah TW (2018) Peripherally restricted cannabinoid 1 receptor agonist as a novel analgesic in cancer-induced bone pain. Pain 159:1814\u20131823","journal-title":"Pain"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2246","DOI":"10.1097\/j.pain.0000000000002214","article-title":"Selective targeting of peripheral cannabinoid receptors prevents behavioral symptoms and sensitization of trigeminal neurons in mouse models of migraine and medication overuse headache","volume":"162","author":"Yamamoto T","year":"2021","unstructured":"Yamamoto T, Mulpuri Y, Izraylev M, Li Q, Simonian M, Kramme C, Schmidt BL, Seltzman HH, Spigelman I (2021) Selective targeting of peripheral cannabinoid receptors prevents behavioral symptoms and sensitization of trigeminal neurons in mouse models of migraine and medication overuse headache. Pain 162:2246\u20132262","journal-title":"Pain"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/0333102418779557","article-title":"Non-invasive dural stimulation in mice: A novel preclinical model of migraine","volume":"39","author":"Burgos-Vega CC","year":"2019","unstructured":"Burgos-Vega CC, Quigley LD, Trevisan Dos Santos G, Yan F, Asiedu M, Jacobs B, Motina M, Safdar N, Yousuf H, Avona A, Price TJ, Dussor G (2019) Non-invasive dural stimulation in mice: A novel preclinical model of migraine. Cephalalgia 39:123\u2013134","journal-title":"Cephalalgia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan SR","year":"1994","unstructured":"Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55\u201363","journal-title":"J Neurosci Methods"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon WJ","year":"1980","unstructured":"Dixon WJ (1980) Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 20:441\u2013462","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1021\/jm201731z","article-title":"Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity","volume":"55","author":"Fulp A","year":"2012","unstructured":"Fulp A, Bortoff K, Seltzman H, Zhang Y, Mathews J, Snyder R, Fennell T, Maitra R (2012) Design and synthesis of cannabinoid receptor 1 antagonists for peripheral selectivity. J Med Chem 55:2820\u20132834","journal-title":"J Med Chem"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.neuroscience.2006.09.053","article-title":"Two types of neurotransmitter release patterns in isolectin B4-positive and negative trigeminal ganglion neurons","volume":"144","author":"Matsuka Y","year":"2007","unstructured":"Matsuka Y, Edmonds B, Mitrirattanakul S, Schweizer FE, Spigelman I (2007) Two types of neurotransmitter release patterns in isolectin B4-positive and negative trigeminal ganglion neurons. Neuroscience 144:665\u2013674","journal-title":"Neuroscience"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/acsptsci.4c00269","article-title":"A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies","volume":"7","author":"Chicca A","year":"2024","unstructured":"Chicca A, B\u00e1tora D, Ullmer C, Caruso A, Gr\u00fcner S, Fingerle J, Hartung T, Degen R, M\u00fcller M, Grether U, Pacher P, Gertsch J (2024) A Highly Potent, Orally Bioavailable Pyrazole-Derived Cannabinoid CB2 Receptor- Selective Full Agonist for In Vivo Studies. ACS Pharmacol Transl Sci 7:2424\u20132438","journal-title":"ACS Pharmacol Transl Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuropharm.2014.12.015","article-title":"ASICs as therapeutic targets for migraine","volume":"94","author":"Dussor G","year":"2015","unstructured":"Dussor G (2015) ASICs as therapeutic targets for migraine. Neuropharmacology 94:64\u201371","journal-title":"Neuropharmacology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12974-017-0916-4","article-title":"Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception","volume":"14","author":"Wu J","year":"2017","unstructured":"Wu J, Liu TT, Zhou YM, Qiu CY, Ren P, Jiao M, Hu WP (2017) Sensitization of ASIC3 by proteinase-activated receptor 2 signaling contributes to acidosis-induced nociception. J Neuroinflammation 14:150","journal-title":"J Neuroinflammation"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.pain.2010.09.036","article-title":"Dural afferents express acid-sensing ion channels: a role for decreased meningeal pH in migraine headache","volume":"152","author":"Yan J","year":"2011","unstructured":"Yan J, Edelmayer RM, Wei X, De Felice M, Porreca F, Dussor G (2011) Dural afferents express acid-sensing ion channels: a role for decreased meningeal pH in migraine headache. Pain 152:106\u2013113","journal-title":"Pain"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1111\/head.12152","article-title":"pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators","volume":"53","author":"Yan J","year":"2013","unstructured":"Yan J, Wei X, Bischoff C, Edelmayer RM, Dussor G (2013) pH-evoked dural afferent signaling is mediated by ASIC3 and is sensitized by mast cell mediators. Headache 53:1250\u20131261","journal-title":"Headache"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuropharm.2015.02.009","article-title":"Acid-Sensing Ion Channels and nociception in the peripheral and central nervous systems","volume":"94","author":"Deval E","year":"2015","unstructured":"Deval E, Lingueglia E (2015) Acid-Sensing Ion Channels and nociception in the peripheral and central nervous systems. Neuropharmacology 94:49\u201357","journal-title":"Neuropharmacology"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.103.059808","article-title":"Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception","volume":"309","author":"Akerman S","year":"2004","unstructured":"Akerman S, Kaube H, Goadsby PJ (2004) Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther 309:56\u201363","journal-title":"J Pharmacol Exp Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/ejn.14897","article-title":"Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine","volume":"55","author":"Kilinc E","year":"2022","unstructured":"Kilinc E, Ankarali S, Torun IE, Dagistan Y (2022) Receptor mechanisms mediating the anti-neuroinflammatory effects of endocannabinoid system modulation in a rat model of migraine. Eur J Neurosci 55:1015\u20131031","journal-title":"Eur J Neurosci"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1124\/jpet.106.106971","article-title":"Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons","volume":"320","author":"Akerman S","year":"2007","unstructured":"Akerman S, Holland PR, Goadsby PJ (2007) Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. J Pharmacol Exp Ther 320:64\u201371","journal-title":"J Pharmacol Exp Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"116670","DOI":"10.1016\/j.lfs.2019.116670","article-title":"Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study","volume":"232","author":"Mohammadi Vosough E","year":"2019","unstructured":"Mohammadi Vosough E, Baradaran Rahimi V, Masoud SA, Mirkarimi HR, Demneh MK, Abed A, Banafshe HR, Askari VR (2019) Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study. Life Sci 232:116670","journal-title":"Life Sci"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1124\/mol.114.094649","article-title":"CB2 Cannabinoid receptors as a therapeutic target-what does the future hold?","volume":"86","author":"Dhopeshwarkar A","year":"2014","unstructured":"Dhopeshwarkar A, Mackie K (2014) CB2 Cannabinoid receptors as a therapeutic target-what does the future hold? Mol Pharmacol 86:430\u2013437","journal-title":"Mol Pharmacol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1111\/bph.70116","article-title":"Cannabinoid CB(2) receptor-mediated analgesia: mechanism-based insights and therapeutic potential","volume":"182","author":"Guenther KG","year":"2025","unstructured":"Guenther KG, Hohmann AG (2025) Cannabinoid CB(2) receptor-mediated analgesia: mechanism-based insights and therapeutic potential. Br J Pharmacol 182:5090\u20135118","journal-title":"Br J Pharmacol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"816747","DOI":"10.3389\/fncir.2021.816747","article-title":"Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation","volume":"15","author":"Hoogen NJ","year":"2021","unstructured":"van den Hoogen NJ, Harding EK, Davidson CED, Trang T (2021) Cannabinoids in Chronic Pain: Therapeutic Potential Through Microglia Modulation. Front Neural Circuits 15:816747","journal-title":"Front Neural Circuits"},{"key":"ref33","article-title":"Microglial Cannabinoid CB(2) Receptors in Pain Modulation","volume":"24","author":"Xu K","year":"2023","unstructured":"Xu K, Wu Y, Tian Z, Xu Y, Wu C, Wang Z (2023) Microglial Cannabinoid CB(2) Receptors in Pain Modulation. Int J Mol Sci 24","journal-title":"Int J Mol Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pnpbp.2011.12.001","article-title":"CB(2): therapeutic target-in-waiting","volume":"38","author":"Atwood BK","year":"2012","unstructured":"Atwood BK, Straiker A, Mackie K (2012) CB(2): therapeutic target-in-waiting. Prog Neuropsychopharmacol Biol Psychiatry 38:16\u201320","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"ref35","article-title":"Cannabinoid CB(2) receptor orthologues; in vitro function and perspectives for preclinical to clinical translation","author":"Carruthers ER","year":"2023","unstructured":"Carruthers ER, Grimsey NL (2023) Cannabinoid CB(2) receptor orthologues; in vitro function and perspectives for preclinical to clinical translation. Br J Pharmacol","journal-title":"Br J Pharmacol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0306-4522(99)00220-1","article-title":"Cannabinoid receptors undergo axonal flow in sensory nerves","volume":"92","author":"Hohmann AG","year":"1999","unstructured":"Hohmann AG, Herkenham M (1999) Cannabinoid receptors undergo axonal flow in sensory nerves. Neuroscience 92:1171\u20131175","journal-title":"Neuroscience"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0306-4522(03)00333-6","article-title":"The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat","volume":"120","author":"Price TJ","year":"2003","unstructured":"Price TJ, Helesic G, Parghi D, Hargreaves KM, Flores CM (2003) The neuronal distribution of cannabinoid receptor type 1 in the trigeminal ganglion of the rat. Neuroscience 120:155\u2013162","journal-title":"Neuroscience"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang J","year":"2003","unstructured":"Zhang J, Hoffert C, Vu HK, Groblewski T, Ahmad S, O'Donnell D (2003) Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models. Eur J Neurosci 17:2750\u20132754","journal-title":"Eur J Neurosci"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"101999","DOI":"10.1016\/j.jbc.2022.101999","article-title":"Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain","volume":"298","author":"Ghosh K","year":"2022","unstructured":"Ghosh K, Zhang GF, Chen H, Chen SR, Pan HL (2022) Cannabinoid CB2 receptors are upregulated via bivalent histone modifications and control primary afferent input to the spinal cord in neuropathic pain. J Biol Chem 298:101999","journal-title":"J Biol Chem"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"116879","DOI":"10.1016\/j.biopha.2024.116879","article-title":"Cannabinoid CB(2) receptors in primary sensory neurons are implicated in CB(2) agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance","volume":"176","author":"Guenther KG","year":"2024","unstructured":"Guenther KG, Lin X, Xu Z, Makriyannis A, Romero J, Hillard CJ, Mackie K, Hohmann AG (2024) Cannabinoid CB(2) receptors in primary sensory neurons are implicated in CB(2) agonist-mediated suppression of paclitaxel-induced neuropathic nociception and sexually-dimorphic sparing of morphine tolerance. Biomed Pharmacother 176:116879","journal-title":"Biomed Pharmacother"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"109601","DOI":"10.1016\/j.neuropharm.2023.109601","article-title":"Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain","volume":"237","author":"Guenther KG","year":"2023","unstructured":"Guenther KG, Xu Z, Romero J, Hillard CJ, Mackie K, Hohmann AG (2023) Conditional deletion of CB2 cannabinoid receptors from peripheral sensory neurons eliminates CB2-mediated antinociceptive efficacy in a mouse model of carrageenan-induced inflammatory pain. Neuropharmacology 237:109601","journal-title":"Neuropharmacology"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/head.12323","article-title":"Ion channels and migraine","volume":"54","author":"Yan J","year":"2014","unstructured":"Yan J, Dussor G (2014) Ion channels and migraine. Headache 54:619\u2013639","journal-title":"Headache"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/S0026-895X(25)15066-9","article-title":"Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes","volume":"26","author":"Howlett AC","year":"1984","unstructured":"Howlett AC, Fleming RM (1984) Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes. Mol Pharmacol 26:532\u2013538","journal-title":"Mol Pharmacol"},{"key":"ref44","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-025-08618-7","article-title":"A cryptic pocket in CB1 drives peripheral and functional selectivity","author":"Rangari VA","year":"2025","unstructured":"Rangari VA, O\u2019Brien ES, Powers AS, Slivicki RA, Bertels Z, Appourchaux K, Aydin D, Ramos-Gonzalez N, Mwirigi J, Lin L, Mangutov E, Sobecks BL, Awad-Agbaria Y, Uphade MB, Aguilar J, Peddada TN, Shiimura Y, Huang X-P, Folarin-Hines J, Payne M, Kalathil A, Varga BR, Kobilka BK, Pradhan AA, Cameron MD, Kumar KK, Dror RO, Gereau RW, Majumdar S (2025) A cryptic pocket in CB1 drives peripheral and functional selectivity. Nature","journal-title":"Nature"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1073\/pnas.252782799","article-title":"cAMP-dependent protein kinase phosphorylation of the acid-sensing ion channel-1 regulates its binding to the protein interacting with C-kinase-1","volume":"100","author":"Leonard AS","year":"2003","unstructured":"Leonard AS, Yermolaieva O, Hruska-Hageman A, Askwith CC, Price MP, Wemmie JA, Welsh MJ (2003) cAMP-dependent protein kinase phosphorylation of the acid-sensing ion channel-1 regulates its binding to the protein interacting with C-kinase-1. Proc Natl Acad Sci U S A 100:2029\u20132034","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"10345","DOI":"10.1523\/JNEUROSCI.18-24-10345.1998","article-title":"Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro","volume":"18","author":"Gold MS","year":"1998","unstructured":"Gold MS, Levine JD, Correa AM (1998) Modulation of TTX-R INa by PKC and PKA and their role in PGE2-induced sensitization of rat sensory neurons in vitro. J Neurosci 18:10345\u201310355","journal-title":"J Neurosci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.celrep.2014.04.039","article-title":"Ca2+\/calcineurin-dependent inactivation of neuronal L-type Ca2\u2009+\u2009channels requires priming by AKAP-anchored protein kinase A","volume":"7","author":"Dittmer PJ","year":"2014","unstructured":"Dittmer PJ, Dell'Acqua ML, Sather WA (2014) Ca2+\/calcineurin-dependent inactivation of neuronal L-type Ca2\u2009+\u2009channels requires priming by AKAP-anchored protein kinase A. Cell Rep 7:1410\u20131416","journal-title":"Cell Rep"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s11302-018-9638-z","article-title":"Adenosine A2A and histamine H3 receptors interact at the cAMP\/PKA pathway to modulate depolarization-evoked [(3)H]-GABA release from rat striato-pallidal terminals","volume":"15","author":"Morales-Figueroa GE","year":"2019","unstructured":"Morales-Figueroa GE, Rivera-Ramirez N, Gonzalez-Pantoja R, Escamilla-Sanchez J, Garcia-Hernandez U, Galvan EJ, Arias-Montano JA (2019) Adenosine A2A and histamine H3 receptors interact at the cAMP\/PKA pathway to modulate depolarization-evoked [(3)H]-GABA release from rat striato-pallidal terminals. Purinergic Signal 15:85\u201393","journal-title":"Purinergic Signal"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.celrep.2014.04.027","article-title":"AKAP-anchored PKA maintains neuronal L-type calcium channel activity and NFAT transcriptional signaling","volume":"7","author":"Murphy JG","year":"2014","unstructured":"Murphy JG, Sanderson JL, Gorski JA, Scott JD, Catterall WA, Sather WA, Dell'Acqua ML (2014) AKAP-anchored PKA maintains neuronal L-type calcium channel activity and NFAT transcriptional signaling. Cell Rep 7:1577\u20131588","journal-title":"Cell Rep"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"16624","DOI":"10.1073\/pnas.1213790109","article-title":"Cyclic AMP-dependent phosphorylation of neuronal nitric oxide synthase mediates penile erection","volume":"109","author":"Hurt KJ","year":"2012","unstructured":"Hurt KJ, Sezen SF, Lagoda GF, Musicki B, Rameau GA, Snyder SH, Burnett AL (2012) Cyclic AMP-dependent phosphorylation of neuronal nitric oxide synthase mediates penile erection. Proc Natl Acad Sci U S A 109:16624\u201316629","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.expneurol.2012.10.006","article-title":"Involvement of PKA-dependent upregulation of nNOS-CGRP in adrenomedullin-initiated mechanistic pathway underlying CFA-induced response in rats","volume":"239","author":"Wang D","year":"2013","unstructured":"Wang D, Ruan L, Hong Y, Chabot JG, Quirion R (2013) Involvement of PKA-dependent upregulation of nNOS-CGRP in adrenomedullin-initiated mechanistic pathway underlying CFA-induced response in rats. Exp Neurol 239:111\u2013119","journal-title":"Exp Neurol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"e0170097","DOI":"10.1371\/journal.pone.0170097","article-title":"Sensitization of TRPA1 by Protein Kinase A","volume":"12","author":"Meents JE","year":"2017","unstructured":"Meents JE, Fischer MJ, McNaughton PA (2017) Sensitization of TRPA1 by Protein Kinase A. PLoS ONE 12:e0170097","journal-title":"PLoS ONE"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.pain.2008.02.022","article-title":"A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1","volume":"138","author":"Jeske NA","year":"2008","unstructured":"Jeske NA, Diogenes A, Ruparel NB, Fehrenbacher JC, Henry M, Akopian AN, Hargreaves KM (2008) A-kinase anchoring protein mediates TRPV1 thermal hyperalgesia through PKA phosphorylation of TRPV1. Pain 138:604\u2013616","journal-title":"Pain"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"e45531","DOI":"10.1371\/journal.pone.0045531","article-title":"Cannabinoids inhibit acid-sensing ion channel currents in rat dorsal root ganglion neurons","volume":"7","author":"Liu YQ","year":"2012","unstructured":"Liu YQ, Qiu F, Qiu CY, Cai Q, Zou P, Wu H, Hu WP (2012) Cannabinoids inhibit acid-sensing ion channel currents in rat dorsal root ganglion neurons. PLoS ONE 7:e45531","journal-title":"PLoS ONE"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1097\/j.pain.0000000000002353","article-title":"Protein kinase C\u03b4 as a neuronal mechanism for headache in a chronic intermittent nitroglycerin model of migraine in mice","volume":"162","author":"He Y","year":"2021","unstructured":"He Y, Shi Z, Kashyap Y, Messing RO, Wang ZJ (2021) Protein kinase C\u03b4 as a neuronal mechanism for headache in a chronic intermittent nitroglycerin model of migraine in mice. Pain 162:2499\u20132511","journal-title":"Pain"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1038\/npp.2008.230","article-title":"PKCepsilon regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212-2","volume":"34","author":"Wallace MJ","year":"2009","unstructured":"Wallace MJ, Newton PM, McMahon T, Connolly J, Huibers A, Whistler J, Messing RO (2009) PKCepsilon regulates behavioral sensitivity, binding and tolerance to the CB1 receptor agonist WIN55,212-2. Neuropsychopharmacology 34:1733\u20131742","journal-title":"Neuropsychopharmacology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8714966\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8714966\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T14:32:40Z","timestamp":1773757960000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-8714966\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":56,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-8714966\/v1","relation":{},"subject":[],"published":{"date-parts":[[2026,3,3]]},"subtype":"preprint"}}